GAYLEEN PRAUSA: Open Payments
NPI 1528286192 · MONUMENT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 33 payments from 10 companies in 2025. Trend: 2023 $698 · 2024 $689 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $313 |
| Janssen Biotech, Inc. | 9 | $168 |
| Ardelyx, Inc. | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Ipsen Biopharmaceuticals, Inc | 2 | $57 |
| Madrigal Pharmaceuticals | 2 | $47 |
| GENZYME CORPORATION | 1 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| QOL Medical, LLC | 1 | $20 |
| PFIZER INC. | 1 | $19 |
Products named: RINVOQ, TREMFYA, CREON, IBSRELA, DUPIXENT, IQIRVO, REZDIFFRA, EOHILIA.
Industry payments across CO — which companies pay providers there.
